In the US, the monthly cost of treatment with GLP-1s is approximately $1,000, and in other advanced markets it is $100-$500
A person taking Wegovy is likely to lose approximately 12% of their body weight, on average, but if they abruptly stop taking the drug, they will likely regain 2/3 of that weight
Results based on users stratified into engagement quartiles during a trial period and then tracking the duration of their paid program membership (Months of persistence by engagement quartile: Q1 = 2.8 , Q4 = 6.2)
Medicare's new Bridge demonstration program sidesteps that law to cover the drugs for obesity at least temporarily for more beneficiaries, including those who are overweight with conditions like prediabetes or uncontrolled hypertension
Optimize GLP-1 Results with bistroMD Chef-prepared, gourmet meals designed to make your GLP-1 lifestyle easyand incredibly effective